Microba Life Sciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Microba Life Sciences has a total shareholder equity of A$41.2M and total debt of A$395.4K, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are A$58.0M and A$16.8M respectively.
Belangrijke informatie
1.0%
Verhouding schuld/eigen vermogen
AU$395.39k
Schuld
| Rente dekkingsratio | n/a |
| Contant | AU$21.09m |
| Aandelen | AU$41.22m |
| Totaal verplichtingen | AU$16.82m |
| Totaal activa | AU$58.04m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: MAP's short term assets (A$32.2M) exceed its short term liabilities (A$12.4M).
Langlopende schulden: MAP's short term assets (A$32.2M) exceed its long term liabilities (A$4.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: MAP has more cash than its total debt.
Schuld verminderen: MAP's debt to equity ratio has reduced from 3.2% to 1% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: MAP has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: MAP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.5% each year